A Phase 3, Multi-center, Open-label, Randomized Study to Evaluate the Efficacy and Safety of JY09 Versus Dulaglutide in Patients With T2DM Inadequately Controlled by Metformin
Latest Information Update: 26 Aug 2024
At a glance
- Drugs JY 09 (Primary) ; Metformin (Primary) ; Dulaglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Beijing Dongfang Biotech
Most Recent Events
- 22 Aug 2024 Status changed from not yet recruiting to recruiting.
- 19 Feb 2024 New trial record